CD19 CAR T cell therapy in severe, seropositive, treatment-refractory rheumatoid arthritis: insights from phase I of the COMPARE trial
Time Period
19.05.2026 | 09:15
This is an hybrid event in English.
Doctoral researchers and postdocs present their research projects in the scientific context. Venue: DRFZ/MPI-IB Charitéplatz 1, 10117 Berlin Campus address: Virchowweg 12
